A share price of Guardant Health Inc [GH] is currently trading at $111.98, up 3.11%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GH shares have gain 2.98% over the last week, with a monthly amount glided 9.07%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on January 05, 2026, when Evercore ISI downgraded its rating to a In-line but kept the price target unchanged to $105 for it. On September 25, 2025, upgrade upgraded it’s rating to Outperform but maintained its price target of $75 on the stock. Mizuho initiated its recommendation with a Outperform and recommended $55 as its price target on April 10, 2025. Barclays started tracking with a Overweight rating for this stock on January 23, 2025, and assigned it a price target of $60. In a note dated June 28, 2024, Guggenheim upgraded an Buy rating on this stock but restated the target price of $36.
Guardant Health Inc experienced fluctuations in its stock price throughout the past year between $34.88 and $113.91. Currently, Wall Street analysts expect the stock to reach $118.46 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $111.98 at the most recent close of the market. An investor can expect a potential return of 5.79% based on the average GH price forecast.
Analyzing the GH fundamentals
Trailing Twelve Months sales for Guardant Health Inc [NASDAQ:GH] were 902.57M which represents 38.50% growth. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.49%, Pretax Profit Margin comes in at -0.44%, and Net Profit Margin reading is -0.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is 1.52 and Total Capital is -0.43. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -3.74.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Guardant Health Inc [NASDAQ:GH] is 3.50. Further, the Quick Ratio stands at 3.12, while the Cash Ratio is 2.45. Considering the valuation of this stock, the price to sales ratio is 16.05.
Transactions by insiders
Recent insider trading involved Monroe Terilyn J., Chief People Officer, that happened on Jan 07 ’26 when 10031.0 shares were sold. Officer, Monroe Terilyn J. completed a deal on Jan 07 ’26 to buy 10031.0 shares. Meanwhile, Director Tariq Musa sold 116.0 shares on Dec 17 ’25.
